[
    {
        "question_id": "1_B_2174",
        "new_question_id": "10194",
        "question_type": "0",
        "category": "6",
        "concept_id_link": "0",
        "notes_id_link": "1_774",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Dermatomyositis",
            "Tinea infection",
            "Psoriasis",
            "Systemic sclerosis",
            "Contact dermatitis",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "During a routine medication review, you notice your patient, a 55 year-old female, has some skin changes. There are purplish plaques on the knuckles of both hands, and the patient's eyelids also appear purple.  She has never suffered from skin problems in the past.  What is the likely diagnosis?",
            "",
            ""
        ],
        "answers": [
            "1",
            "",
            ""
        ],
        "notes": [
            "This is a description of the typical skin changes seen in dermatomyositis, a connective tissue disease.  In addition to the plaques on the knuckles (Gottron's papules) and eyelids (heliotrope rash) there may be scaling of the scalp and changes to the nail beds and cuticles.  There is inflammation of the proximal muscles causing weakness, but the skin changes often are the first presenting feature.  Dermatomyositis is usually an autoimmune condition, in which case it is controlled with immunosuppressants, but may also be a paraneoplastic syndrome.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "During a routine medication review, you notice your patient, a 55 year-old female, has some skin changes. There are purplish plaques on the knuckles of both hands, and the patient's eyelids also appear purple.  She has never suffered from skin problems in the past.  What is the likely diagnosis?",
        "correct_answer": "1",
        "question_notes": "This is a description of the typical skin changes seen in dermatomyositis, a connective tissue disease.  In addition to the plaques on the knuckles (Gottron's papules) and eyelids (heliotrope rash) there may be scaling of the scalp and changes to the nail beds and cuticles.  There is inflammation of the proximal muscles causing weakness, but the skin changes often are the first presenting feature.  Dermatomyositis is usually an autoimmune condition, in which case it is controlled with immunosuppressants, but may also be a paraneoplastic syndrome.",
        "answer_order": "1",
        "answer": "1",
        "title": "Dermatomyositis",
        "body": "Overview<br /><ul><li>an inflammatory disorder causing symmetrical, proximal muscle weakness and characteristic skin lesions</li><li>may be idiopathic or associated with connective tissue disorders or <span class=\"concept\" data-cid=\"2709\">underlying malignancy</span> (typically ovarian, breast and lung cancer, found in 20-25% - more if patient older). <span class=\"concept\" data-cid=\"4160\">Screening for an underlying malignancy</span> is usually performed following a diagnosis of dermatomyositis</li><li>polymyositis is a variant of the disease where skin manifestations are not prominent</li></ul><br />Skin features<br /><ul><li>photosensitive</li><li>macular rash over back and shoulder</li><li>heliotrope rash in the periorbital region</li><li><span class=\"concept\" data-cid=\"2665\">Gottron's papules - roughened red papules over extensor surfaces of fingers</span></li><li> 'mechanic's hands': extremely dry and scaly hands with linear 'cracks' on the palmar and lateral aspects of the fingers</li><li>nail fold capillary dilatation</li></ul><br />Other features<br /><ul><li>proximal muscle weakness +/- tenderness</li><li>Raynaud's</li><li>respiratory muscle weakness</li><li>interstitial lung disease: e.g. Fibrosing alveolitis or organising pneumonia</li><li>dysphagia, dysphonia</li></ul><br />Investigations<br /><ul><li>the majority of patients (around 80%) are ANA positive</li><li>around 30% of patients have antibodies to aminoacyl-tRNA synthetases (anti-synthetase antibodies), including:<ul><li><span class=\"concept\" data-cid=\"9286\">antibodies against histidine-tRNA ligase (also called Jo-1)</span></li><li>antibodies to signal recognition particle (SRP)</li><li>anti-Mi-2 antibodies</li></ul></li></ul>",
        "notes_hash": "b4954774d646eebc091d256ac2500f83",
        "knowledge_graph_node_id_link": 1416,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "5162",
        "up_votes": "42",
        "down_votes": "17",
        "column_array": [
            0,
            "3977",
            "74",
            "379",
            "635",
            "97",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>DermNet NZ</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_2030\" data-linkid=\"2030\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_2030\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">24</span><button type=\"button\" style=\"\" id=\"link_dislike_2030\" data-linkid=\"2030\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_2030\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">15</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://dermnetnz.org/topics/adult-onset-dermatomyositis/\">Dermatomyositis</a></td></tr></table><br><br><table style='width:100%'><tr><td>Primary Care Dermatology Society</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_2031\" data-linkid=\"2031\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_2031\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">11</span><button type=\"button\" style=\"\" id=\"link_dislike_2031\" data-linkid=\"2031\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_2031\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">6</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"http://www.pcds.org.uk/clinical-guidance/dermatomyositis\">Dermatomyositis (including polymyositis)</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/cZbj0EhOFQI\" data-description=\"Polymyositis and Dermatomyositis in 3 Minutes\" data-upvotes=\"39\" data-downvotes=\"3\" data-media=\"1395\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/cZbj0EhOFQI/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/cZbj0EhOFQI\" data-description=\"Polymyositis and Dermatomyositis in 3 Minutes\" data-upvotes=\"39\" data-downvotes=\"3\" data-media=\"1395\">Polymyositis and Dermatomyositis in 3 Minutes</a></td></tr><tr><td><span ><small>Townsend Teaching - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2457\" data-mediaid=\"2457\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2457\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">39</span><button type=\"button\" style=\"\" id=\"media_dislike_2457\" data-mediaid=\"2457\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2457\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">3</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/FGAEw97Etb4\" data-description=\"Understanding Myositis (Polymyositis and Dermatomyositis)\" data-upvotes=\"5\" data-downvotes=\"5\" data-media=\"1498\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/FGAEw97Etb4/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/FGAEw97Etb4\" data-description=\"Understanding Myositis (Polymyositis and Dermatomyositis)\" data-upvotes=\"5\" data-downvotes=\"5\" data-media=\"1498\">Understanding Myositis (Polymyositis and Dermatomyositis)</a></td></tr><tr><td><span ><small>Zero To Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2637\" data-mediaid=\"2637\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2637\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">5</span><button type=\"button\" style=\"\" id=\"media_dislike_2637\" data-mediaid=\"2637\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2637\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">5</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ekRZkjTlgro\" data-description=\"Dermatomyositis Overview\" data-upvotes=\"1\" data-downvotes=\"2\" data-media=\"1554\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/ekRZkjTlgro/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ekRZkjTlgro\" data-description=\"Dermatomyositis Overview\" data-upvotes=\"1\" data-downvotes=\"2\" data-media=\"1554\">Dermatomyositis Overview</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2708\" data-mediaid=\"2708\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2708\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">1</span><button type=\"button\" style=\"\" id=\"media_dislike_2708\" data-mediaid=\"2708\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2708\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr></table>",
        "comment_count": 5,
        "concepts_for_notes": {
            "2665": {
                "concept_text": "Gottron's papules, roughened red papules over the knuckles mainly, are seen in dermatomyositis \r\n",
                "concept_percentile": "73"
            },
            "9286": {
                "concept_text": "Dermatomyositis is associated with the anti-Jo-1 antibody",
                "concept_percentile": "47"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_E_88",
        "new_question_id": "4493",
        "question_type": "1",
        "category": "11",
        "concept_id_link": "0",
        "notes_id_link": "1_1751",
        "theme": "Ovarian cysts",
        "instruction": "For each one of the following please select the answer from the list above:",
        "options": [
            "",
            "Dermoid cyst (teratoma)",
            "Endometriotic cyst",
            "Granulosa cell tumour",
            "Clear cell tumour",
            "Corpus luteum cyst",
            "Mucinous cystadenoma",
            "Follicular cyst",
            "Serous carcinoma",
            "Polycystic ovarian syndrome",
            "Fibroma"
        ],
        "num_of_options": 10,
        "questions": [
            "Sometimes referred to as chocolate cysts due to the external appearance",
            "Znk suyz iussut ubgxogt igtikx",
            "Gt arzxgyuatj jutk ut g 23-ekgx-urj lksgrk lux xkiaxxktz axotgxe zxgiz otlkizouty otiojktzgrre ynucy g 3 is 'yosvrk ieyz' ut znk rklz ubgxe. Ynk oy gyesvzusgzoi"
        ],
        "answers": [
            "2",
            "8",
            "7"
        ],
        "notes": [
            "",
            "Around 90% of ovarian cancers are epithelial in origin.",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "Sometimes referred to as chocolate cysts due to the external appearance",
        "correct_answer": "2",
        "question_notes": "",
        "answer_order": "2",
        "answer": "2",
        "title": "Ovarian cysts: types",
        "body": "Benign ovarian cysts are extremely common. They may be divided into physiological cysts, benign germ cell tumours, benign epithelial tumours and benign sex cord stromal tumours.<br /><br /><span class=\"concept\" data-cid=\"9588\">Complex (i.e. multi-loculated) ovarian cysts should be biopsied to exclude malignancy.</span><br /><br /><h5 class='notes-heading'>Physiological cysts (functional cysts)</h5><br />Follicular cysts<br /><ul><li><span class=\"concept\" data-cid=\"3315\">commonest type of ovarian cyst</span></li><li>due to non-rupture of the dominant follicle or failure of atresia in a non-dominant follicle</li><li>commonly regress after several menstrual cycles</li></ul><br />Corpus luteum cyst<br /><ul><li>during the menstrual cycle if pregnancy doesn't occur the corpus luteum usually breaks down and disappears. If this doesn't occur the corpus luteum may fill with blood or fluid and form a corpus luteal cyst</li><li>more likely to present with intraperitoneal bleeding than follicular cysts</li></ul><br /><h5 class='notes-heading'>Benign germ cell tumours</h5><br />Dermoid cyst<br /><ul><li>also called mature cystic teratomas. Usually lined with epithelial tissue and hence may contain skin appendages, hair and teeth</li><li>most common benign ovarian tumour in woman under the age of 30 years</li><li>median age of diagnosis is 30 years old</li><li>bilateral in 10-20%</li><li>usually asymptomatic. Torsion is more likely than with other ovarian tumours</li></ul><br /><h5 class='notes-heading'>Benign epithelial tumours</h5><br />Arise from the ovarian surface epithelium<br /><br /><span class=\"concept\" data-cid=\"12354\">Serous cystadenoma</span><br /><ul><li>most common benign epithelial tumour, typically seen in middle-aged women</li><li>typically unilocular or multilocular with thin walls</li><li>bilateral in around 20%</li><li>presentation: often asymptomatic; may present with pelvic pressure or discomfort if large</li><li>imaging: ultrasound shows a thin-walled, anechoic or low-level echo cyst; may have thin septations; usually no solid components or papillary projections</li></ul><br />Mucinous cystadenoma<br /><ul><li>second most common benign epithelial tumour</li><li>typically unilateral but can become very large, sometimes >30 cm</li><li>presentation: abdominal distension, discomfort, or pressure symptoms (e.g. urinary frequency, bowel disturbance)</li><li>imaging: multiloculated cyst with varying echogenicity on ultrasound due to mucin content; septations may be more prominent than in serous tumours</li><li>if ruptures may cause pseudomyxoma peritonei</li></ul>",
        "notes_hash": "ea4badd8c2cbbfea72aa626f49257218",
        "knowledge_graph_node_id_link": 0,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "5070",
        "up_votes": "43",
        "down_votes": "42",
        "column_array": [
            0,
            "3240",
            "2625",
            "3732",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/u0Jfkq_Z5GU\" data-description=\"Ovarian cysts\" data-upvotes=\"18\" data-downvotes=\"1\" data-media=\"851\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/u0Jfkq_Z5GU/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/u0Jfkq_Z5GU\" data-description=\"Ovarian cysts\" data-upvotes=\"18\" data-downvotes=\"1\" data-media=\"851\">Ovarian cysts</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1492\" data-mediaid=\"1492\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1492\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">18</span><button type=\"button\" style=\"\" id=\"media_dislike_1492\" data-mediaid=\"1492\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1492\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/lCOnSW2hkV4\" data-description=\"Ovarian tumors\" data-upvotes=\"3\" data-downvotes=\"4\" data-media=\"341\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/lCOnSW2hkV4/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/lCOnSW2hkV4\" data-description=\"Ovarian tumors\" data-upvotes=\"3\" data-downvotes=\"4\" data-media=\"341\">Ovarian tumors</a></td></tr><tr><td><span ><small>12DaysinMarch - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_581\" data-mediaid=\"581\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_581\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">3</span><button type=\"button\" style=\"\" id=\"media_dislike_581\" data-mediaid=\"581\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_581\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">4</span></td></tr></table>",
        "comment_count": 2,
        "concepts_for_notes": {
            "3315": {
                "concept_text": "The follicular cyst is the most common type of ovarian cyst",
                "concept_percentile": "93"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1479_B_200",
        "new_question_id": "7267",
        "question_type": "0",
        "category": "1",
        "concept_id_link": "0",
        "notes_id_link": "1_245",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Propranolol",
            "Ramipril",
            "Indapamide",
            "Amlodipine",
            "Aspirin",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 77-year-old man reports ongoing leg swelling and says that he is 'struggling to breathe' at night. A B-type natriuretic peptide (BNP) blood test is done which is found to be raised. Therefore, an echocardiogram is performed which reveals heart failure with reduced ejection fraction. His past medical history includes diabetes for which he is currently taking metformin. <br /><br />In addition to furosemide for symptomatic control, what else should this patient be started on for his heart failure? <br />",
            "",
            ""
        ],
        "answers": [
            "2",
            "",
            ""
        ],
        "notes": [
            "Patients with heart failure should be started on an angiotensin-converting enzyme (ACE) inhibitor and a beta-blocker licensed to treat heart failure, however, only one drug should be started at a time.<br /><br />An ACE-inhibitor (such as ramipril) is preferred if the person has diabetes mellitus or has signs of fluid overload.<br /><br />A beta-blocker is preferred, if the person has angina. Beta-blockers licensed to treat heart failure in the UK include bisoprolol, carvedilol, and nebivolol.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 77-year-old man reports ongoing leg swelling and says that he is 'struggling to breathe' at night. A B-type natriuretic peptide (BNP) blood test is done which is found to be raised. Therefore, an echocardiogram is performed which reveals heart failure with reduced ejection fraction. His past medical history includes diabetes for which he is currently taking metformin. <br /><br />In addition to furosemide for symptomatic control, what else should this patient be started on for his heart failure? <br />",
        "correct_answer": "2",
        "question_notes": "Patients with heart failure should be started on an angiotensin-converting enzyme (ACE) inhibitor and a beta-blocker licensed to treat heart failure, however, only one drug should be started at a time.<br /><br />An ACE-inhibitor (such as ramipril) is preferred if the person has diabetes mellitus or has signs of fluid overload.<br /><br />A beta-blocker is preferred, if the person has angina. Beta-blockers licensed to treat heart failure in the UK include bisoprolol, carvedilol, and nebivolol.",
        "answer_order": "2",
        "answer": "2",
        "title": "Chronic heart failure: drug management",
        "body": "NICE issued updated guidelines on management in 2018, key points are summarised here.<br /><br />Whilst loop diuretics play an important role in managing fluid overload it should be remembered that no long-term reduction in mortality has been demonstrated for <span class=\"concept\" data-cid=\"4533\">loop diuretics</span> such as furosemide.<br /><br /><h5 class='notes-heading'>First-line therapy</h5><br />The first-line treatment for all patients is both an <span class=\"concept\" data-cid=\"1608\"><b>ACE-inhibitor</b> and a <b>beta-blocker</b></span><br /><ul><li>generally, <span class=\"concept\" data-cid=\"8883\">one drug should be started at a time</span>. NICE advise that clinical judgement is used when determining which one to start first</li><li>beta-blockers licensed to treat heart failure in the UK include <span class=\"concept\" data-cid=\"9704\">bisoprolol, carvedilol, and nebivolol</span>.</li><li>ACE-inhibitors and beta-blockers have no effect on mortality in heart failure with <span class=\"concept\" data-cid=\"8881\"><i>preserved</i></span> ejection fraction </li></ul><br /><h5 class='notes-heading'>Second-line therapy</h5><br />The standard second-line treatment is an <span class=\"concept\" data-cid=\"9528\"><b>aldosterone antagonist</b></span><br /><ul><li>these are sometimes referred to as mineralocorticoid receptor antagonists. Examples include spironolactone and eplerenone</li><li>it should be remembered that both ACE inhibitors (which the patient is likely to already be on) and aldosterone antagonists both cause hyperkalaemia - therefore potassium should be monitored </li></ul><br />There is an increasing role for <span class=\"concept\" data-cid=\"11988\"><b>SGLT-2 inhibitors</b></span> in the management of heart failure with a reduced ejection fraction<br /><ul><li>these drugs reduce glucose reabsorption and increase urinary glucose excretion</li><li>examples include canagliflozin, dapagliflozin and empagliflozin</li><li>the evidence base shows  SGLT-2 inhibitors reduced hospitalisation secondary to heart failure and cardiovascular death</li><li>international guidelines widely recommend their usage. In terms of NICE, a technology appraisal from 2021 support the use of dapagliflozin as an add-on to optimised standard care</li></ul><br /><h5 class='notes-heading'>Third-line therapy</h5><br />Third-line treatment should be initiated by a specialist. Options include ivabradine, sacubitril-valsartan, hydralazine in combination with nitrate, digoxin and cardiac resynchronisation therapy<br /><ul><li>ivabradine<ul><li>criteria: <span class=\"concept\" data-cid=\"10964\">sinus rhythm > 75/min and a left ventricular fraction < 35%</span></li></ul></li><li><span class=\"concept\" data-cid=\"2407\">sacubitril-valsartan</span><ul><li>criteria: left ventricular fraction < 35%</li><li>is considered in heart failure with reduced ejection fraction who are symptomatic on ACE inhibitors or ARBs</li><li><span class=\"concept\" data-cid=\"9700\">should be initiated following ACEi or ARB wash-out period</span></li></ul></li><li>digoxin<ul><li>digoxin has also not been proven to reduce mortality in patients with heart failure. It may however improve symptoms due to its inotropic properties</li><li>it is strongly indicated if there is coexistent <span class=\"concept\" data-cid=\"2862\">atrial fibrillation</span></li></ul></li><li>hydralazine in combination with nitrate<ul><li>this may be particularly indicated in <span class=\"concept\" data-cid=\"3665\">Afro-Caribbean patients</span></li></ul></li><li>cardiac resynchronisation therapy<ul><li>indications include a <span class=\"concept\" data-cid=\"10963\">widened QRS (e.g. left bundle branch block) complex on ECG</span></li></ul></li></ul><br />Other treatments<br /><ul><li>offer <span class=\"concept\" data-cid=\"9705\"><b>annual influenza vaccine</b></span></li><li>offer one-off <b>pneumococcal vaccine</b><ul><li>adults usually require just one dose but those with asplenia, splenic dysfunction or chronic kidney disease need a booster every 5 years</li></ul></li></ul><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd975b.png\" data-fancybox=\"gallery\" data-caption=\"\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd975.png\" alt=\"\" /></a></div></div></div>",
        "notes_hash": "ef7b09917f0a69047baab0b3496da189",
        "knowledge_graph_node_id_link": 1072,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "6255",
        "up_votes": "66",
        "down_votes": "27",
        "column_array": [
            0,
            "817",
            "4784",
            "275",
            "314",
            "65",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_265\" data-linkid=\"265\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_265\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">16</span><button type=\"button\" style=\"\" id=\"link_dislike_265\" data-linkid=\"265\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_265\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">18</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ta267/chapter/1-Guidance\">2012 Guidance on ivabradine</a></td></tr></table><br><br><table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1065\" data-linkid=\"1065\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1065\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">36</span><button type=\"button\" style=\"\" id=\"link_dislike_1065\" data-linkid=\"1065\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1065\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">23</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng106/chapter/Recommendations\">2018 Chronic heart failure guidelines</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/q2t9sFITAIY\" data-description=\"Chronic Heart Failure: Visual Explanation for Students\" data-upvotes=\"23\" data-downvotes=\"0\" data-media=\"775\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/q2t9sFITAIY/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/q2t9sFITAIY\" data-description=\"Chronic Heart Failure: Visual Explanation for Students\" data-upvotes=\"23\" data-downvotes=\"0\" data-media=\"775\">Chronic Heart Failure: Visual Explanation for Students</a></td></tr><tr><td><span ><small>Zero To Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1347\" data-mediaid=\"1347\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1347\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">23</span><button type=\"button\" style=\"\" id=\"media_dislike_1347\" data-mediaid=\"1347\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1347\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ifxS8JMJR6k\" data-description=\"Heart failure\" data-upvotes=\"4\" data-downvotes=\"3\" data-media=\"914\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/ifxS8JMJR6k/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ifxS8JMJR6k\" data-description=\"Heart failure\" data-upvotes=\"4\" data-downvotes=\"3\" data-media=\"914\">Heart failure</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1586\" data-mediaid=\"1586\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1586\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">4</span><button type=\"button\" style=\"\" id=\"media_dislike_1586\" data-mediaid=\"1586\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1586\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">3</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ItKGeEbzAis\" data-description=\"Heart failure with reduced and preserved ejection fraction\" data-upvotes=\"6\" data-downvotes=\"6\" data-media=\"1467\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/ItKGeEbzAis/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ItKGeEbzAis\" data-description=\"Heart failure with reduced and preserved ejection fraction\" data-upvotes=\"6\" data-downvotes=\"6\" data-media=\"1467\">Heart failure with reduced and preserved ejection fraction</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2582\" data-mediaid=\"2582\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2582\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">6</span><button type=\"button\" style=\"\" id=\"media_dislike_2582\" data-mediaid=\"2582\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2582\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">6</span></td></tr></table>",
        "comment_count": 4,
        "concepts_for_notes": {
            "1608": {
                "concept_text": "Patients with heart failure with reduced LVEF should be given a beta blocker and an ACE inhibitor as first-line treatment",
                "concept_percentile": "78"
            },
            "2862": {
                "concept_text": "Digoxin is strongly indicated if there is co-existent atrial fibrillation with chronic heart failure",
                "concept_percentile": "89"
            },
            "9528": {
                "concept_text": "Offer a mineralcorticoid receptor antagonist, in addition to an ACE inhibitor (or ARB) and beta-blocker, to people who have heart failure with reduced ejection fraction if they continue to have symptoms of heart failure",
                "concept_percentile": "86"
            },
            "11988": {
                "concept_text": "SGLT-2 inhibitors should be considered as second-line therapy in patients with HFrEF in addition to optimised standard care",
                "concept_percentile": "60"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "17834_B_11",
        "new_question_id": "29751",
        "question_type": "0",
        "category": "3",
        "concept_id_link": "1234",
        "notes_id_link": "1_1134",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Fixed-rate IV insulin infusion (0.1 units/kg/hour) AND continue injectable long-acting insulin only",
            "Fixed-rate IV insulin infusion (0.1 units/kg/hour) AND continue injectable short-acting and long-acting insulin",
            "Fixed-rate IV insulin infusion (0.1 units/kg/hour) AND stop all injectable insulins",
            "Variable-rate IV insulin infusion (0.1 units/kg/hour) AND continue injectable long-acting insulin only",
            "Variable-rate IV insulin infusion (0.1 units/kg/hour) AND continue injectable short-acting and long-acting insulin",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 24-year-old man presents to the emergency department with abdominal pain, vomiting and lethargy. His mother informs you he first developed 'flu-like symptoms' around four days ago. The patient has a diagnosis of type 1 diabetes. He is on a basal-bolus regimen but has not been taking his insulin regularly since he became unwell. On examination, he is confused and is hyperventilating. His blood glucose is 22 mmol/L (<11.1 mmol/L) and his blood ketone level is 4.0 mmol/L (<0.6 mmol/L). <br /><br />You request an arterial blood gas (ABG).<br /><br /><div class=\"table-responsive\"><table class = \"tb\" ><tbody><tr><td>pH</td><td>7.19</td><td>(7.35-7.45)</td></tr><tr><td>pO2</td><td>14.0 kPa</td><td>(10-14 kPa)</td></tr><tr><td>pCO2</td><td>3.6 kPa</td><td>(4.5-6.0 kPa)</td></tr><tr><td>Bicarbonate</td><td>12 mmol/L</td><td>(22-28 mmol/L)</td></tr></tbody></table></div><br />You start the patient on IV resuscitation fluids.<br /><br />Following this, what is the next most appropriate step in management?",
            "",
            ""
        ],
        "answers": [
            "1",
            "0",
            "0"
        ],
        "notes": [
            "This patient has all three features of diabetic ketoacidosis (DKA): hyperglycaemia, ketonaemia and metabolic acidosis. He also has a background history of type 1 diabetes.<br /><br />Fixed-rate IV insulin infusion (0.1 units/kg/hour) AND continue injectable long-acting insulin only is the correct answer. In the acute setting, patients with DKA should be started on a fixed-rate insulin infusion. Their long-acting insulin should be continued and their short-acting insulin stopped.<br /><br />Fixed-rate IV insulin infusion (0.1 units/kg/hour) AND continue injectable short-acting and long-acting insulin is incorrect. Injectable short-acting insulin should be stopped.<br /><br />Fixed-rate IV insulin infusion (0.1 units/kg/hour) AND stop all injectable insulins is incorrect. Only the short-acting insulin should be stopped.<br /><br />Variable-rate IV insulin infusion (0.1 units/kg/hour) AND continue injectable long-acting insulin only is incorrect. The patient should receive a fixed-rate insulin infusion.<br /><br />Variable-rate IV insulin infusion (0.1 units/kg/hour) AND continue injectable short-acting and long-acting insulin is incorrect. The patient should receive a fixed-rate insulin infusion and the short-acting insulin should be stopped.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 24-year-old man presents to the emergency department with abdominal pain, vomiting and lethargy. His mother informs you he first developed 'flu-like symptoms' around four days ago. The patient has a diagnosis of type 1 diabetes. He is on a basal-bolus regimen but has not been taking his insulin regularly since he became unwell. On examination, he is confused and is hyperventilating. His blood glucose is 22 mmol/L (<11.1 mmol/L) and his blood ketone level is 4.0 mmol/L (<0.6 mmol/L). <br /><br />You request an arterial blood gas (ABG).<br /><br /><div class=\"table-responsive\"><table class = \"tb\" ><tbody><tr><td>pH</td><td>7.19</td><td>(7.35-7.45)</td></tr><tr><td>pO2</td><td>14.0 kPa</td><td>(10-14 kPa)</td></tr><tr><td>pCO2</td><td>3.6 kPa</td><td>(4.5-6.0 kPa)</td></tr><tr><td>Bicarbonate</td><td>12 mmol/L</td><td>(22-28 mmol/L)</td></tr></tbody></table></div><br />You start the patient on IV resuscitation fluids.<br /><br />Following this, what is the next most appropriate step in management?",
        "correct_answer": "1",
        "question_notes": "This patient has all three features of diabetic ketoacidosis (DKA): hyperglycaemia, ketonaemia and metabolic acidosis. He also has a background history of type 1 diabetes.<br /><br />Fixed-rate IV insulin infusion (0.1 units/kg/hour) AND continue injectable long-acting insulin only is the correct answer. In the acute setting, patients with DKA should be started on a fixed-rate insulin infusion. Their long-acting insulin should be continued and their short-acting insulin stopped.<br /><br />Fixed-rate IV insulin infusion (0.1 units/kg/hour) AND continue injectable short-acting and long-acting insulin is incorrect. Injectable short-acting insulin should be stopped.<br /><br />Fixed-rate IV insulin infusion (0.1 units/kg/hour) AND stop all injectable insulins is incorrect. Only the short-acting insulin should be stopped.<br /><br />Variable-rate IV insulin infusion (0.1 units/kg/hour) AND continue injectable long-acting insulin only is incorrect. The patient should receive a fixed-rate insulin infusion.<br /><br />Variable-rate IV insulin infusion (0.1 units/kg/hour) AND continue injectable short-acting and long-acting insulin is incorrect. The patient should receive a fixed-rate insulin infusion and the short-acting insulin should be stopped.",
        "answer_order": "1",
        "answer": "1",
        "title": "Diabetic ketoacidosis",
        "body": "Diabetic ketoacidosis (DKA) may be a complication of existing type 1 diabetes mellitus or be the first presentation, accounting for around 6% of cases.  Rarely, under conditions of extreme stress, patients with <span class=\"concept\" data-cid=\"5494\">type 2 diabetes mellitus</span> may also develop DKA.<br /><br />Whilst DKA remains a serious condition, mortality rates have decreased from 8% to under 1% in the past 20 years.<br /><br />Pathophysiology<br /><ul><li><span class=\"concept\" data-cid=\"7735\">DKA is caused by uncontrolled lipolysis (not proteolysis) which results in an excess of free fatty acids that are ultimately converted to ketone bodies</span></li></ul><br />The most common precipitating factors of DKA are infection, missed insulin doses and <span class=\"concept\" data-cid=\"3699\">myocardial infarction</span>.<br /><br />Features<br /><ul><li><span class=\"concept\" data-cid=\"5413\">abdominal pain</span></li><li>polyuria, polydipsia, dehydration</li><li>Kussmaul respiration (deep hyperventilation)</li><li>Acetone-smelling breath ('pear drops' smell)</li></ul><br /><h5 class='notes-heading'>Diagnostic criteria</h5><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th>American Diabetes Association (2009)</th><th>Joint British Diabetes Societies (2013)</th></tr></thead><tbody><tr><td>Key points<br /><ul><li>glucose > 13.8 mmol/l</li><li>pH < 7.30</li><li>serum bicarbonate <18 mmol/l</li><li>anion gap > 10</li><li>ketonaemia</td><td></li></ul>Key points<br /><ul><li>glucose > 11 mmol/l or known diabetes mellitus</li><li>pH < 7.3</li><li>bicarbonate < 15 mmol/l</li><li><span class=\"concept\" data-cid=\"5493\">ketones > 3 mmol/l</span> or urine ketones ++ on dipstick</td></tr></tbody></table></div></li></ul><br /><h5 class='notes-heading'>Management</h5><br />Main principles of management<br /><ul><li>fluid replacement<ul><li>most patients with DKA are deplete around 5-8 litres</li><li><span class=\"concept\" data-cid=\"11273\">isotonic saline</span> is used initially, even if the patient is severely acidotic</li><li>please see an example fluid regime below.</li></ul></li><li>insulin<ul><li>an intravenous infusion should be started at <span class=\"concept\" data-cid=\"11414\">0.1 unit/kg/hour</span></li><li>once blood glucose <span class=\"concept\" data-cid=\"11983\">is < 14 mmol/l an infusion of 10% dextrose should be started at 125 mls/hr <i>in addition</i> to the 0.9% sodium chloride regime</span></li></ul></li><li>correction of electrolyte disturbance<ul><li>serum potassium is often high on admission despite total body potassium being low</li><li>this often falls quickly following treatment with insulin resulting in hypokalaemia</li><li>potassium may therefore need to be added to the replacement fluids</li><li>if the rate of potassium infusion is greater than 20 mmol/hour then cardiac monitoring may be required</li></ul></li><li><span class=\"concept\" data-cid=\"1234\">long-acting insulin should be continued, short-acting insulin should be stopped</span></li></ul><br /><h6 class='notes-subheading'>JBDS example of fluid replacement regime for patient with a systolic BP on admission 90mmHg and over</h6><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid2\" ><thead><tr><th>Fluid</th><th>Volume</th></tr></thead><tbody><tr><td>0.9% sodium chloride 1L</td><td>1000ml over 1st hour</td></tr><tr><td>0.9% sodium chloride 1L with potassium chloride</td><td>1000ml over next 2 hours</td></tr><tr><td>0.9% sodium chloride 1L with potassium chloride</td><td>1000ml over next 2 hours</td></tr><tr><td>0.9% sodium chloride 1L with potassium chloride</td><td>1000ml over next 4 hours</td></tr><tr><td>0.9% sodium chloride 1L with potassium chloride</td><td>1000ml over next 4 hours</td></tr><tr><td>0.9% sodium chloride 1L with potassium chloride</td><td>1000ml over next 6 hours</td></tr></tbody></table></div><br />Please note that slower infusion may be indicated in young adults (aged 18-25 years) as they are at greater risk of cerebral oedema.<br /><br /><h6 class='notes-subheading'>JBDS potassium guidelines</h6><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid3\" ><thead><tr><th>Potassium level in first 24 hours (mmol/L)</th><th>Potassium replacement in mmol/L of infusion solution</th></tr></thead><tbody><tr><td>Over 5.5</td><td>Nil</td></tr><tr><td>3.5-5.5</td><td><span class=\"concept\" data-cid=\"11276\">40</span></td></tr><tr><td>Below 3.5</td><td>Senior review as additional potassium needs to be given</td></tr></tbody></table></div><br /><h5 class='notes-heading'>Resolution</h5><br /><span class=\"concept\" data-cid=\"2649\">DKA resolution is defined</span> as:<br /><ul><li>pH >7.3 and </li><li>blood ketones < 0.6 mmol/L and</li><li>bicarbonate > 15.0mmol/L</li></ul> <br />Further points<br /><ul><li>both the <span class=\"concept\" data-cid=\"11277\">ketonaemia and acidosis should have been resolved within 24 hours</span>. If this hasn't happened the patient requires senior review from an endocrinologist</li><li>if the above criteria are met and the patient is eating and drinking switch to subcutaneous insulin</li><li>the patient should be reviewed by the diabetes specialist nurse prior to discharge</li></ul><br /><h5 class='notes-heading'>Complications</h5><br />Complications may occur from DKA itself or the treatment:<br /><ul><li>gastric stasis</li><li>thromboembolism</li><li>arrhythmias secondary to hyperkalaemia/iatrogenic hypokalaemia</li><li>iatrogenic due to incorrect fluid therapy: <span class=\"concept\" data-cid=\"1290\">cerebral oedema</span>*, hypokalaemia, hypoglycaemia</li><li>acute respiratory distress syndrome</li><li>acute kidney injury</li></ul><br />* <span class=\"concept\" data-cid=\"1290\">children/young adults are particularly vulnerable to cerebral oedema</span> following fluid resuscitation in DKA and often need 1:1 nursing to monitor neuro-observations, headache, irritability, visual disturbance, focal neurology etc. It usually occurs 4-12 hours following commencement of treatment but can present at any time. If there is any suspicion a CT head and senior review should be sought",
        "notes_hash": "22116a034fe21294322cc27e68874af2",
        "knowledge_graph_node_id_link": 1066,
        "concept": "In the acute management of DKA, insulin should be fixed rate whilst continuing regular injected long-acting insulin but stopping short actin injected insulin",
        "concept_percentile": "57",
        "concept_colour": "rgb(219,255,0)",
        "number_attempts": "7958",
        "up_votes": "31",
        "down_votes": "10",
        "column_array": [
            0,
            "5664",
            "183",
            "906",
            "1093",
            "112",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Joint British Inpatient Diabetes Societies Inpatient Care Group</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1025\" data-linkid=\"1025\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1025\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">32</span><button type=\"button\" style=\"\" id=\"link_dislike_1025\" data-linkid=\"1025\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1025\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">24</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://abcd.care/sites/abcd.care/files/site_uploads/JBDS_Guidelines_Current/JBDS_02_DKA_Guideline_with_QR_code_March_2023.pdf\">The Management of Diabetic ketoacidosis in adults</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/-B-RVybvffU\" data-description=\"Diabetes mellitus (type 1, type 2) &amp; diabetic ketoacidosis (DKA) - causes &amp; symptoms\" data-upvotes=\"2\" data-downvotes=\"1\" data-media=\"14\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/-B-RVybvffU/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/-B-RVybvffU\" data-description=\"Diabetes mellitus (type 1, type 2) &amp; diabetic ketoacidosis (DKA) - causes &amp; symptoms\" data-upvotes=\"2\" data-downvotes=\"1\" data-media=\"14\">Diabetes mellitus (type 1, type 2) &amp; diabetic ketoacidosis (DKA) - causes &amp; symptoms</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1783\" data-mediaid=\"1783\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1783\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"media_dislike_1783\" data-mediaid=\"1783\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1783\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/FxOXPVW4ZCc\" data-description=\"Diabetic Ketoacidosis (Diabetes Type I) Management Summary\" data-upvotes=\"5\" data-downvotes=\"3\" data-media=\"399\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/FxOXPVW4ZCc/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/FxOXPVW4ZCc\" data-description=\"Diabetic Ketoacidosis (Diabetes Type I) Management Summary\" data-upvotes=\"5\" data-downvotes=\"3\" data-media=\"399\">Diabetic Ketoacidosis (Diabetes Type I) Management Summary</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_683\" data-mediaid=\"683\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_683\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">5</span><button type=\"button\" style=\"\" id=\"media_dislike_683\" data-mediaid=\"683\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_683\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">3</span></td></tr></table>",
        "comment_count": 3,
        "concepts_for_notes": {
            "1234": {
                "concept_text": "In the acute management of DKA, insulin should be fixed rate whilst continuing regular injected long-acting insulin but stopping short actin injected insulin",
                "concept_percentile": "57"
            },
            "5413": {
                "concept_text": "Abdominal pain may be the presenting symptom in DKA\r\n",
                "concept_percentile": "64"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_2059",
        "new_question_id": "8930",
        "question_type": "0",
        "category": "4",
        "concept_id_link": "0",
        "notes_id_link": "1_505",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Achalasia",
            "Globus hystericus",
            "Oesophageal spasm",
            "Oesophageal carcinoma",
            "Bulbar palsy",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 60-year-old man comes to see you in GP complaining of difficulty in swallowing, which has been getting slowly worse over the past 3 months. After taking a full history you discover that he has lost around two kilos in weight, although he puts this down to not eating as much, he has no pain when swallowing and has not had any episodes of regurgitating food.<br /><br />While he is telling you this, you notice that his voice sounds a little different to how it normally is.<br /><br />What is the most likely diagnosis?",
            "",
            ""
        ],
        "answers": [
            "4",
            "0",
            "0"
        ],
        "notes": [
            "Progressive dysphagia is characteristic of oesophageal carcinoma, and with the addition of weight loss, this needs to be investigated urgently for possible oesophageal carcinoma. With oesophageal cancer there can also be hoarseness due to laryngeal nerve damage. <br /><br />Achalasia can have a similar presentation, but patients notice mostly trouble with swallowing solids and liquids equally and starts intermittently, regurgitation of food is also a feature. <br /><br />Patients with oesophageal spasm characteristically have pain when swallowing.<br /><br />Bulbar palsy presents with symptoms of weakness, such as drooling, weak and wasted tongue, dysphonia and problems articulating.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 60-year-old man comes to see you in GP complaining of difficulty in swallowing, which has been getting slowly worse over the past 3 months. After taking a full history you discover that he has lost around two kilos in weight, although he puts this down to not eating as much, he has no pain when swallowing and has not had any episodes of regurgitating food.<br /><br />While he is telling you this, you notice that his voice sounds a little different to how it normally is.<br /><br />What is the most likely diagnosis?",
        "correct_answer": "4",
        "question_notes": "Progressive dysphagia is characteristic of oesophageal carcinoma, and with the addition of weight loss, this needs to be investigated urgently for possible oesophageal carcinoma. With oesophageal cancer there can also be hoarseness due to laryngeal nerve damage. <br /><br />Achalasia can have a similar presentation, but patients notice mostly trouble with swallowing solids and liquids equally and starts intermittently, regurgitation of food is also a feature. <br /><br />Patients with oesophageal spasm characteristically have pain when swallowing.<br /><br />Bulbar palsy presents with symptoms of weakness, such as drooling, weak and wasted tongue, dysphonia and problems articulating.",
        "answer_order": "4",
        "answer": "4",
        "title": "Oesophageal cancer",
        "body": "Until recent times oesophageal cancer was most commonly due to a squamous cell carcinoma but the incidence of adenocarcinoma is rising rapidly. Adenocarcinoma is now the most common type of oesophageal cancer and is more likely to develop in patients with a <span class=\"concept\" data-cid=\"723\">history of gastro-oesophageal reflux disease (GORD) or Barrett's</span>.<br /><br />The majority of adenocarcinomas are located near the gastroesophageal junction whereas squamous cell tumours are most commonly found in the upper two-thirds of the oesophagus.<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th></th><th>Adenocarcinoma</th><th>Squamous cell cancer</th></tr></thead><tbody><tr><td><b>Epidemiology</b></td><td>Most common type in the UK/US</td><td>Most common type in the developing world</td></tr><tr><td><b>Location</b></td><td>Lower third - near the gastroesophageal junction</td><td>Upper two-thirds of the oesophagus</td></tr><tr><td><b>Risk factors</b></td><td><ul><li><span class=\"concept\" data-cid=\"723\">GORD</span></li><li><span class=\"concept\" data-cid=\"723\">Barrett's oesophagus</span></li><li>smoking</li><li>obesity</li></ul></td><td><ul><li><span class=\"concept\" data-cid=\"12348\">smoking</span></li><li><span class=\"concept\" data-cid=\"12348\">alcohol</span></li><li>achalasia</li><li><span class=\"concept\" data-cid=\"1933\">Plummer-Vinson syndrome</span></li><li>diets rich in nitrosamines</td></tr></tbody></table></div></li></ul><br />Features<br /><ul><li>dysphagia: the most common presenting symptom</li><li>anorexia and weight loss</li><li>vomiting</li><li>other possible features include: <ul><li><span class=\"concept\" data-cid=\"10981\">odynophagia</span></li><li><span class=\"concept\" data-cid=\"12367\">hoarseness</span>: advanced oesophageal tumours, especially in the upper third, may invade or compress the recurrent laryngeal nerve</li><li>melaena</li></ul></li></ul><br />Diagnosis<br /><ul><li>Upper GI endoscopy with biopsy is used for diagnosis</li><li><span class=\"concept\" data-cid=\"8995\">Endoscopic ultrasound</span>  is the preferred method for locoregional staging</li><li>CT scanning of the chest, abdomen and pelvis is used for initial staging<ul><li>FDG-PET CT may be used for detecting occult metastases if metastases are not seen on the initial staging CT scans. </li><li>Laparoscopy is sometimes performed to detect occult peritoneal disease</li></ul></li></ul><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/xrb095b.jpg\" data-fancybox=\"gallery\" data-caption=\"Barium swallow - 5cm irregular narrowing of the mid-thoracic oesophagus with proximal shouldering- e Image used on license from Radiopaedia\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/xrb095.jpg\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/xrb197b.jpg\" data-fancybox=\"gallery\" data-caption=\"Barium swallow showing oesophageal cancer - e Image used on license from Radiopaedia\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/xrb197.jpg\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/xrb096b.jpg\" data-fancybox=\"gallery\" data-caption=\"Fluoroscopy - a region of fixed, irregular stricturing is seen in the distal oesophagus- e Image used on license from Radiopaedia\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/xrb096.jpg\" alt=\"\" /></a></div></div></div><br />Treatment<br /><ul><li>Operable disease (T1N0M0) is best managed by <span class=\"concept\" data-cid=\"12070\">surgical resection</span> - the most common procedure is an Ivor-Lewis type oesophagectomy</li><li>The biggest surgical challenge is that of anastomotic leak, with an intrathoracic anastomosis resulting in mediastinitis</li><li>In addition to surgical resection many patients will be treated with adjuvant chemotherapy</li></ul>",
        "notes_hash": "0fae7d191dd71c66d2b36b6d3155b561",
        "knowledge_graph_node_id_link": 1039,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "7464",
        "up_votes": "38",
        "down_votes": "35",
        "column_array": [
            0,
            "298",
            "215",
            "87",
            "6058",
            "806",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1746\" data-linkid=\"1746\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1746\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">15</span><button type=\"button\" style=\"\" id=\"link_dislike_1746\" data-linkid=\"1746\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1746\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">12</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng83/chapter/Recommendations\">2018 Oesophago-gastric cancer: assessment and management in adults guidelines</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/8c8UkAqvZxk\" data-description=\"Oesophageal cancer\" data-upvotes=\"4\" data-downvotes=\"1\" data-media=\"1129\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/8c8UkAqvZxk/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/8c8UkAqvZxk\" data-description=\"Oesophageal cancer\" data-upvotes=\"4\" data-downvotes=\"1\" data-media=\"1129\">Oesophageal cancer</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1953\" data-mediaid=\"1953\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1953\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">4</span><button type=\"button\" style=\"\" id=\"media_dislike_1953\" data-mediaid=\"1953\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1953\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr></table>",
        "comment_count": 5,
        "concepts_for_notes": {
            "723": {
                "concept_text": "Oesophageal adenocarcinoma is associated with GORD or Barrett's",
                "concept_percentile": "86"
            },
            "10981": {
                "concept_text": "Odynophagia is a concerning symptom that may be present in patients with oesophageal cancer",
                "concept_percentile": "61"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "2084_B_367",
        "new_question_id": "14772",
        "question_type": "0",
        "category": "3",
        "concept_id_link": "3281",
        "notes_id_link": "1_1432",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Sickle-cell anaemia",
            "Hereditary spherocytosis",
            "G6PD deficiency",
            "Splenectomy",
            "Beta-thalassaemia",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 53-year-old man is admitted to hospital with a chest infection and has a set of routine bloods done in the emergency department. His HbA1c result is shown below:<br /><br /><div class=\"table-responsive\"><table class = \"tb\" ><tbody><tr><td>HbA1c</td><td>48 mmol/mol (27-48 mmol/mol)</td></tr></tbody></table></div><br />Which of the following medical conditions would mean this result would over-estimate his blood sugar levels?",
            "",
            ""
        ],
        "answers": [
            "4",
            "0",
            "0"
        ],
        "notes": [
            "Measuring HbA1c levels is becoming the most common test for diabetes as it provides an average blood glucose level over a period of time of about 3 months. This corresponds to the life span of a normal red blood cell. The two things that can result in a higher HbA1c reading are a higher average blood glucose concentration and a longer red cell life span. Therefore, the only condition here which would result in the HbA1c being an over-estimate of blood sugar would be a previous splenectomy as this would increase the red blood cell life span. All the other conditions would decrease their life span and consequently reduce the HbA1c.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 53-year-old man is admitted to hospital with a chest infection and has a set of routine bloods done in the emergency department. His HbA1c result is shown below:<br /><br /><div class=\"table-responsive\"><table class = \"tb\" ><tbody><tr><td>HbA1c</td><td>48 mmol/mol (27-48 mmol/mol)</td></tr></tbody></table></div><br />Which of the following medical conditions would mean this result would over-estimate his blood sugar levels?",
        "correct_answer": "4",
        "question_notes": "Measuring HbA1c levels is becoming the most common test for diabetes as it provides an average blood glucose level over a period of time of about 3 months. This corresponds to the life span of a normal red blood cell. The two things that can result in a higher HbA1c reading are a higher average blood glucose concentration and a longer red cell life span. Therefore, the only condition here which would result in the HbA1c being an over-estimate of blood sugar would be a previous splenectomy as this would increase the red blood cell life span. All the other conditions would decrease their life span and consequently reduce the HbA1c.",
        "answer_order": "4",
        "answer": "4",
        "title": "Glycosylated haemoglobin",
        "body": "Glycosylated haemoglobin (HbA1c) is the most widely used measure of long-term glycaemic control in diabetes mellitus. HbA1c is produced by the glycosylation of haemoglobin at a rate proportional to the glucose concentration. The level of HbA1c therefore is dependent on:<br /><ul><li>red blood cell lifespan</li><li>average blood glucose concentration</li></ul><br />A number of conditions can interfere with accurate HbA1c interpretation:<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><b>Lower-than-expected levels of HbA1c</b> (due to reduced red blood cell lifespan)</th><th><b>Higher-than-expected levels of HbA1c</b> (due to increased red blood cell lifespan)</th></tr></thead><tbody><tr><td><span class=\"concept\" data-cid=\"3282\">Sickle-cell anaemia</span><br />GP6D deficiency <br /><span class=\"concept\" data-cid=\"3356\">Hereditary spherocytosis</span><br /><span class=\"concept\" data-cid=\"11893\">Haemodialysis</span></td><td>Vitamin B12/folic acid deficiency<br />Iron-deficiency anaemia<br /><span class=\"concept\" data-cid=\"3281\">Splenectomy</span></td></tr></tbody></table></div><br />HbA1c is generally thought to reflect the blood glucose over the previous '3 months' although there is some evidence it is weighed more strongly to glucose levels of the past 2-4 weeks. NICE recommend <i>'HbA1c should be checked every 3-6 months until stable, then 6 monthly'.</i><br /><br />The relationship between HbA1c and average blood glucose is complex but has been studied by the Diabetes Control and Complications Trial (DCCT). A new internationally standardised method for reporting HbA1c has been developed by the International Federation of Clinical Chemistry (IFCC). This will report HbA1c in mmol per mol of haemoglobin without glucose attached.<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid2\" ><thead><tr><th><b>HBA1c<br />(%)</b></th><th><b>Average plasma glucose<br />(mmol/l)</b></th><th><b>IFCC-HbA1c (mmol/mol)</b></th></tr></thead><tbody><tr><td>5</td><td>5.5</td></tr><tr><td>6</td><td>7.5</td><td>42</td></tr><tr><td>7</td><td>9.5</td><td>53</td></tr><tr><td>8</td><td>11.5</td><td>64</td></tr><tr><td>9</td><td>13.5</td><td>75</td></tr><tr><td>10</td><td>15.5</td></tr><tr><td>11</td><td>17.5</td></tr><tr><td>12</td><td>19.5</td></tr></tbody></table></div>",
        "notes_hash": "3666da263667a5cb0b898e91a6a5fd00",
        "knowledge_graph_node_id_link": 0,
        "concept": "Splenectomy can give a falsely high HbA1c level due to the increased lifespan of RBCs",
        "concept_percentile": "84",
        "concept_colour": "rgb(81,255,0)",
        "number_attempts": "4927",
        "up_votes": "79",
        "down_votes": "26",
        "column_array": [
            0,
            "1139",
            "476",
            "467",
            "2547",
            "298",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>DocStoc</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_60\" data-linkid=\"60\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_60\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">6</span><button type=\"button\" style=\"\" id=\"link_dislike_60\" data-linkid=\"60\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_60\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">12</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://i.pinimg.com/originals/e3/b6/bb/e3b6bb6702d58c6a5cbfe60ecdf16ead.png\">HbA1c conversion chart</a></td></tr></table>",
        "media": "",
        "comment_count": 8,
        "concepts_for_notes": {
            "3281": {
                "concept_text": "Splenectomy can give a falsely high HbA1c level due to the increased lifespan of RBCs",
                "concept_percentile": "84"
            },
            "3282": {
                "concept_text": "Sickle cell anaemia and other haemoglobinopathies can give falsely low HbA1c readings due the decreased lifespan of RBCs",
                "concept_percentile": "69"
            },
            "3356": {
                "concept_text": "HbA1c UNDERestimates glucose levels in hereditary spherocytosis",
                "concept_percentile": "41"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "5348_B_10",
        "new_question_id": "16161",
        "question_type": "0",
        "category": "9",
        "concept_id_link": "4344",
        "notes_id_link": "1_298",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Middle meningeal artery",
            "Bridging vein",
            "Anterior circulating artery",
            "Internal cerebral veins",
            "Basilar artery",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "You and your consultant are reviewing a CT head of an elderly patient who presented to the emergency department with reduced consciousness after a fall, hitting the side of their head. Your consultant describes a unilateral crescentic lesion in the right frontoparietal area.<br /><br />What vessel has most likely been damaged?",
            "",
            ""
        ],
        "answers": [
            "2",
            "0",
            "0"
        ],
        "notes": [
            "Subdural haemorrhage is the most likely cause of reduced consciousness in this case. It is caused by damage to bridging veins between the cortex and venous sinuses. On CT it classically presents as a crescent shaped lesion, and as they occur in the subdural space, cross sutures.<br /><br />Epidural haemorrhage is associated with the middle meningeal artery<br /><br />Subarachnoid haemorrhages are associated with vessels of the circle of Willis, such as basilar and anterior circulating arteries.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "You and your consultant are reviewing a CT head of an elderly patient who presented to the emergency department with reduced consciousness after a fall, hitting the side of their head. Your consultant describes a unilateral crescentic lesion in the right frontoparietal area.<br /><br />What vessel has most likely been damaged?",
        "correct_answer": "2",
        "question_notes": "Subdural haemorrhage is the most likely cause of reduced consciousness in this case. It is caused by damage to bridging veins between the cortex and venous sinuses. On CT it classically presents as a crescent shaped lesion, and as they occur in the subdural space, cross sutures.<br /><br />Epidural haemorrhage is associated with the middle meningeal artery<br /><br />Subarachnoid haemorrhages are associated with vessels of the circle of Willis, such as basilar and anterior circulating arteries.",
        "answer_order": "2",
        "answer": "2",
        "title": "Subdural haemorrhage",
        "body": "A subdural haematoma is a collection of blood deep to the dural layer of the meninges. The blood is not within the substance of the brain and is therefore called an 'extra-axial' or 'extrinsic' lesion. They can be unilateral or bilateral.<br /><br />Subdural haematomas can be classified in terms of their age:<br /><ul><li><b>Acute</b>: Symptoms usually develop within 48 hours of injury, characterised by rapid neurological deterioration</li><li><b>Subacute</b>: Symptoms manifest within days to weeks post-injury, with a more gradual progression.</li><li><b>Chronic</b>: Common in the elderly, developing over weeks to months. Patients may not recall a specific head injury.</li></ul><br />The typical presentation of a subdural haematoma (SDH) often involves a history of head trauma, which may range from minor to severe. Patients frequently exhibit a lucid interval followed by a gradual decline in consciousness. This pattern is particularly common in chronic SDH. Other hallmark features include headache, confusion, and lethargy.<br /><br /><h5 class='notes-heading'>Clinical Features</h5><br />Neurological Symptoms:<br /><ul><li>Altered Mental Status: Ranging from mild confusion to deep coma. <span class=\"concept\" data-cid=\"619\">Fluctuations in the level of consciousness are common.</span></li><li>Focal Neurological Deficits: Weakness on one side of the body, aphasia, or visual field defects, depending on the haematoma's location.</li><li>Headache: Often localised to one side, worsening over time.</li><li>Seizures: May occur, particularly in acute or expanding hematomas.</li></ul><br />Physical Examination Findings:<br /><ul><li>Papilloedema: Indicates raised intracranial pressure.</li><li>Pupil Changes: Unilateral dilated pupil, especially on the side of the haematoma, indicating compression of the third cranial nerve.</li><li>Gait Abnormalities: Including ataxia or weakness in one leg.</li><li>Hemiparesis or Hemiplegia: Reflecting the mass effect and midline shift.</li></ul><br />Behavioural and Cognitive Changes:<br /><ul><li>Memory Loss: Especially in chronic SDH.</li><li>Personality Changes: Irritability, apathy, or depression.</li><li>Cognitive Impairment: Difficulty with attention, problem-solving, and other executive functions.</li></ul><br />Other Associated Features:<br /><ul><li>Nausea and Vomiting: Secondary to increased intracranial pressure.</li><li>Drowsiness: Progressing to stupor and coma in severe cases.</li><li>Signs of Increased Intracranial Pressure: Such as bradycardia, hypertension, and respiratory irregularities (Cushing's triad).</li></ul><br />Although the collection of blood is within the same anatomical compartment, acute and chronic subdurals have important differences in terms of their mechanisms, associated clinical features and management:<br /><br /><h5 class='notes-heading'>Acute subdural haematoma</h5><br />An acute subdural haematoma is a collection of fresh blood within the subdural space and is most commonly caused by high-impact trauma. Since it is associated with high-impact injuries, there is often other brain underlying brain injuries.<br /><br />There is a spectrum of severity of symptoms and presentation depending on the size of the compressive acute subdural haematoma and the associated injuries. Presentation ranges from an incidental finding in trauma to severe coma and coning due to herniation.<br /><br />CT imaging is the first-line investigation and will show a crescentic collection, not limited by suture lines. They will appear hyperdense (bright) in comparison to the brain. Large acute subdural haematomas will push on the brain ('mass effect') and cause midline shift or herniation.<br /><br />Small or incidental acute subdurals can be observed conservatively. Surgical options include monitoring of intracranial pressure and decompressive craniectomy.<br /><br /><br /><h5 class='notes-heading'>Chronic subdural haematoma</h5><br />A chronic subdural haematoma is a collection of blood within the subdural space that has been present for weeks to months. <br /><br />Rupture of the small bridging veins within the subdural space rupture and cause slow bleeding. Elderly and alcoholic patients are particularly at risk of subdural haematomas since they have brain atrophy and therefore fragile or taut bridging veins. <br /><br />Presentation is typically a several week to month progressive history of either confusion, reduced consciousness or neurological deficit.<br /><br />Infants also have fragile bridging veins and can rupture in shaken baby syndrome.<br /><br />On CT imaging they similarly are crescentic in shape, not restricted by suture lines and compress the brain ('mass effect'). In contrast to acute subdurals, chronic subdurals are <span class=\"concept\" data-cid=\"5102\">hypodense (dark)</span> compared to the substance of the brain.<br /><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/xrb946b.jpg\" data-fancybox=\"gallery\" data-caption=\"CT (non-contrast) showing subdural haematoma in an elderly woman. Mass effect and midline shift - e Image used on license from Radiopaedia\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/xrb946.jpg\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/xrb031b.jpg\" data-fancybox=\"gallery\" data-caption=\"Subdural haematoma - e Image used on license from Radiopaedia\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/xrb031.jpg\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/xrb002b.jpg\" data-fancybox=\"gallery\" data-caption=\"Subdural haematoma - e Image used on license from Radiopaedia\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/xrb002.jpg\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/xrb983b.jpg\" data-fancybox=\"gallery\" data-caption=\"There is a large crescent-shaped area of high density over the right side of the brain, extending from the top (right medial convexity) to the bottom (right temporal lobe). This has caused a midline shift of brain structures, along with subfalcine herniation (where brain tissue is pushed under the falx cerebri).\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/xrb983.jpg\" alt=\"\" /></a></div></div><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/xrb985b.jpg\" data-fancybox=\"gallery\" data-caption=\"Subdural haematoma with significant midline shift\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/xrb985.jpg\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/xrb986b.jpg\" data-fancybox=\"gallery\" data-caption=\"Subdural haematoma\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/xrb986.jpg\" alt=\"\" /></a></div></div></div><br />If the chronic subdural is an incidental finding or if it is small in size with no associated neurological deficit then it can be managed conservatively with the hope that it will dissolve with time. If the patient is confused, has an associated neurological deficit or has severe imaging findings then <span class=\"concept\" data-cid=\"1192\">surgical decompression with burr holes</span> is required.",
        "notes_hash": "b087a8858351f7ec44227242b8dd209c",
        "knowledge_graph_node_id_link": 1156,
        "concept": "Subdural haemorrhage results from bleeding of damaged bridging veins between the cortex and venous sinuses",
        "concept_percentile": "73",
        "concept_colour": "rgb(137,255,0)",
        "number_attempts": "4982",
        "up_votes": "65",
        "down_votes": "32",
        "column_array": [
            0,
            "1924",
            "2406",
            "450",
            "119",
            "83",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Radiopaedia</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_2121\" data-linkid=\"2121\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_2121\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">7</span><button type=\"button\" style=\"\" id=\"link_dislike_2121\" data-linkid=\"2121\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_2121\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">4</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://radiopaedia.org/articles/subdural-haemorrhage?lang=gb\">Subdural haemorrhage</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Kb_wzb7-rvE\" data-description=\"Intracranial Haemorrhage Types\" data-upvotes=\"4\" data-downvotes=\"0\" data-media=\"280\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/Kb_wzb7-rvE/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Kb_wzb7-rvE\" data-description=\"Intracranial Haemorrhage Types\" data-upvotes=\"4\" data-downvotes=\"0\" data-media=\"280\">Intracranial Haemorrhage Types</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_481\" data-mediaid=\"481\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_481\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">4</span><button type=\"button\" style=\"\" id=\"media_dislike_481\" data-mediaid=\"481\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_481\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/hssdJu-81g4\" data-description=\"Traumatic brain injury: pathology review\" data-upvotes=\"9\" data-downvotes=\"1\" data-media=\"1259\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/hssdJu-81g4/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/hssdJu-81g4\" data-description=\"Traumatic brain injury: pathology review\" data-upvotes=\"9\" data-downvotes=\"1\" data-media=\"1259\">Traumatic brain injury: pathology review</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2219\" data-mediaid=\"2219\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2219\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">9</span><button type=\"button\" style=\"\" id=\"media_dislike_2219\" data-mediaid=\"2219\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2219\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/opnVo7GNZ68\" data-description=\"Intracranial bleeds - Subdural and Extradural haematoma\" data-upvotes=\"6\" data-downvotes=\"2\" data-media=\"318\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/opnVo7GNZ68/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/opnVo7GNZ68\" data-description=\"Intracranial bleeds - Subdural and Extradural haematoma\" data-upvotes=\"6\" data-downvotes=\"2\" data-media=\"318\">Intracranial bleeds - Subdural and Extradural haematoma</a></td></tr><tr><td><span ><small>Soton Brain Hub - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_539\" data-mediaid=\"539\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_539\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">6</span><button type=\"button\" style=\"\" id=\"media_dislike_539\" data-mediaid=\"539\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_539\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr></table>",
        "comment_count": 7,
        "concepts_for_notes": {
            "5102": {
                "concept_text": "On CT imaging, a chronic subdural haematoma will appear as a hypodense (dark), crescentic collection around the convexity of the brain",
                "concept_percentile": "91"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "12941_B_265",
        "new_question_id": "30627",
        "question_type": "0",
        "category": "9",
        "concept_id_link": "1130",
        "notes_id_link": "1_2158",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Cerebellum",
            "Frontal lobe",
            "Occipital lobe",
            "Parietal lobe",
            "Temporal lobe",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 72-year-old man is brought to the emergency department by ambulance, following a suspected stroke. On examination, his speech is non-fluent, although his comprehension is normal. When asked to repeat a phrase, he struggles to do this.<br /><br />Where is the most likely site of the lesion?",
            "",
            ""
        ],
        "answers": [
            "2",
            "0",
            "0"
        ],
        "notes": [
            "This is a 2-stage question, with the first part being establishing the type of speech abnormality that the patient has and then followed by identifying the most likely lesion site. Firstly, the above scenario describes a patient with non-fluent speech, normal comprehension, and impaired repetition. This is most likely Broca's dysphasia, which is associated with a frontal lobe lesion affecting Broca's area.<br /><br /><div class='alert alert-warning'>When replying to a conversation, we can imagine how Wernicke's and Broca's areas may interact:<br /><br />Spoken word is heard at the ear. This passes to Wernicke's area in the temporal lobe (near the ear) to comprehend what was said. Once understood, the signal passes along the arcuate fasciculus, before reaching Broca's area. The Broca's area in the frontal lobe (near the mouth) then generates a signal to coordinate the mouth to speak what is thought (fluent speech).<br /></div><br />The cerebellum is incorrect. A lesion in the cerebellum will likely cause cerebellar symptoms, which can be remembered using DANISH: dysdiadochokinesia, ataxia, nystagmus, intention tremor, slurred speech, and hypotonia. The above scenario better describes Broca's dysphasia, rather than simply slurred speech.<br /><br />The occipital lobe is not correct. The occipital lobe plays a vital role in the processing of signals from the eyes, allowing vision. A lesion here would instead cause symptoms such as homonymous hemianopia.<br /><br />The parietal lobe is incorrect. The parietal lobe plays roles in language and processing somatosensory information (such as awareness of the body in space). It would not be associated with Broca's dysphasia, as described above.<br /><br />The temporal lobe is not correct. Whilst a lesion in the temporal lobe could cause dysphasia, this would instead be a Wernicke's dysphasia due to Wernicke's area being affected. This Wernicke's dysphasia would instead present with fluent speech but no comprehension.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 72-year-old man is brought to the emergency department by ambulance, following a suspected stroke. On examination, his speech is non-fluent, although his comprehension is normal. When asked to repeat a phrase, he struggles to do this.<br /><br />Where is the most likely site of the lesion?",
        "correct_answer": "2",
        "question_notes": "This is a 2-stage question, with the first part being establishing the type of speech abnormality that the patient has and then followed by identifying the most likely lesion site. Firstly, the above scenario describes a patient with non-fluent speech, normal comprehension, and impaired repetition. This is most likely Broca's dysphasia, which is associated with a frontal lobe lesion affecting Broca's area.<br /><br /><div class='alert alert-warning'>When replying to a conversation, we can imagine how Wernicke's and Broca's areas may interact:<br /><br />Spoken word is heard at the ear. This passes to Wernicke's area in the temporal lobe (near the ear) to comprehend what was said. Once understood, the signal passes along the arcuate fasciculus, before reaching Broca's area. The Broca's area in the frontal lobe (near the mouth) then generates a signal to coordinate the mouth to speak what is thought (fluent speech).<br /></div><br />The cerebellum is incorrect. A lesion in the cerebellum will likely cause cerebellar symptoms, which can be remembered using DANISH: dysdiadochokinesia, ataxia, nystagmus, intention tremor, slurred speech, and hypotonia. The above scenario better describes Broca's dysphasia, rather than simply slurred speech.<br /><br />The occipital lobe is not correct. The occipital lobe plays a vital role in the processing of signals from the eyes, allowing vision. A lesion here would instead cause symptoms such as homonymous hemianopia.<br /><br />The parietal lobe is incorrect. The parietal lobe plays roles in language and processing somatosensory information (such as awareness of the body in space). It would not be associated with Broca's dysphasia, as described above.<br /><br />The temporal lobe is not correct. Whilst a lesion in the temporal lobe could cause dysphasia, this would instead be a Wernicke's dysphasia due to Wernicke's area being affected. This Wernicke's dysphasia would instead present with fluent speech but no comprehension.",
        "answer_order": "2",
        "answer": "2",
        "title": "Aphasia",
        "body": "The table below lists the major types of aphasia. Remember that dysarthria is different and refers to a motor speech disorder.<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><b>Type of aphasia</b></th><th><b>Notes</b></th></tr></thead><tbody><tr><td><span class=\"concept\" data-cid=\"1128\">Wernicke's (receptive) aphasia</span></td><td>Due to a lesion of the <span class=\"concept\" data-cid=\"4340\">superior temporal gyrus</span>. It is typically supplied by the inferior division of the <span class=\"concept\" data-cid=\"8758\">left MCA</span> <br /><br />This area 'forms' the speech before 'sending it' to Broca's area. Lesions result in sentences that make no sense, word substitution and neologisms but speech remains fluent - 'word salad'<br /><br />Comprehension is impaired</td></tr><tr><td><span class=\"concept\" data-cid=\"1130\">Broca's (expressive) aphasia</span></td><td>Due to a <span class=\"concept\" data-cid=\"9938\">lesion of the inferior frontal gyrus</span>. It is typically supplied by the superior division of the <span class=\"concept\" data-cid=\"8759\">left MCA</span> <br /><br />Speech is non-fluent, laboured, and halting. Repetition is impaired<br /><br />Comprehension is normal</td></tr><tr><td><span class=\"concept\" data-cid=\"1129\">Conduction aphasia</span></td><td><span class=\"concept\" data-cid=\"9941\">Classically due to a stroke affecting the arcuate fasiculus - the connection between Wernicke's and Broca's area</span><br /><br />Speech is fluent but repetition is poor. Aware of the errors they are making<br /><br />Comprehension is normal</td></tr><tr><td>Global aphasia</td><td>Large lesion affecting all 3 of the above areas resulting in severe expressive and receptive aphasia<br /><br />May still be able to communicate using gestures</td></tr></tbody></table></div><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd556b.png'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd556.png'/></a></td></tr><tr><td valign='top' align='left'></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd556b.png'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><div class='imagetext'>Diagram showing the main types of aphasia</div>",
        "notes_hash": "18f3cff49e46a12f14afa92687fac158",
        "knowledge_graph_node_id_link": 0,
        "concept": "Broca's dysphasia: speech non-fluent, comprehension normal, repetition impaired",
        "concept_percentile": "71",
        "concept_colour": "rgb(147,255,0)",
        "number_attempts": "4978",
        "up_votes": "132",
        "down_votes": "19",
        "column_array": [
            0,
            "167",
            "1946",
            "110",
            "1399",
            "1356",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/G9SZJxjDJpc\" data-description=\"Aphasia\" data-upvotes=\"12\" data-downvotes=\"6\" data-media=\"1204\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/G9SZJxjDJpc/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/G9SZJxjDJpc\" data-description=\"Aphasia\" data-upvotes=\"12\" data-downvotes=\"6\" data-media=\"1204\">Aphasia</a></td></tr><tr><td><span ><small>Medicoapps - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2112\" data-mediaid=\"2112\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2112\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">12</span><button type=\"button\" style=\"\" id=\"media_dislike_2112\" data-mediaid=\"2112\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2112\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">6</span></td></tr></table>",
        "comment_count": 7,
        "concepts_for_notes": {
            "1128": {
                "concept_text": "Wernicke's dysphasia: speech fluent, comprehension abnormal, repetition impaired",
                "concept_percentile": "59"
            },
            "1130": {
                "concept_text": "Broca's dysphasia: speech non-fluent, comprehension normal, repetition impaired",
                "concept_percentile": "71"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "2084_B_262",
        "new_question_id": "29505",
        "question_type": "0",
        "category": "4",
        "concept_id_link": "11281",
        "notes_id_link": "1_2943",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Attempt to close the wound with sutures on the ward and arrange a senior review",
            "Cover the wound with sterile saline-soaked gauze and administer antibiotics while awaiting a senior review",
            "Redress the wound, pass a nasogastric tube for drainage and administer antibiotics whilst awaiting a senior review",
            "Resuscitate the patient with fluids and antibiotics and arrange a CT scan",
            "Resuscitate the patient with fluids and antibiotics and arrange for him to be returned to theatre",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 57-year-old man is recovering on the ward following an urgent laparotomy and ileocolic resection for Crohn's disease. On the fifth day post-operatively you are asked to review his abdominal wound due to concerns from the nursing staff. There is obvious wound dehiscence in the central part of his laparotomy incision and small bowel is visible.<br /><br />What are the most appropriate initial steps to be taken in this scenario?",
            "",
            ""
        ],
        "answers": [
            "2",
            "0",
            "0"
        ],
        "notes": [
            "Wound dehiscence is when a surgical wound reopens, either partially or entirely. It can occur any time after an operation and affect any surgical wound on any part of the body. A number of factors increase the risk of dehiscence including infection, malnutrition and poor surgical technique. The emergency management of abdominal wound dehiscence is important to know as junior doctors are almost certainly going to be the first person to confront this problem on the ward when it occurs. The initial management is treating with intravenous antibiotics, covering the wound with sterile gauze soaked in sterile saline to ensure the abdominal contents do not dry out and arranging for the patient to be taken to theatre for a wound repair.<br /><br />Attempting to close the wound on the ward yourself is both unlikely to succeed and unsafe as the risk of infection or bowel injury is high.<br /><br />A nasogastric tube is not indicated and simply redressing the wound without applying moist gauze is likely to risk transudative volume loss from the abdominal contents. An open body compartment can result in a significant loss of fluid if not managed appropriately and this makes this option less appropriate. Additionally, there is a risk of passing a nasogastric tube with an open abdomen as it can cause coughing and abdominal muscle straining and result in widening of the wound defect.<br /><br />Arranging a CT scan is not necessary in this situation, the problem is very obvious and a scan will only delay definitive management.<br /><br />Although antibiotics and returning to theatre are both required, not dealing with the open wound in any way is a poor choice. Leaving an open wound uncovered risks both fluid loss and infection entering.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 57-year-old man is recovering on the ward following an urgent laparotomy and ileocolic resection for Crohn's disease. On the fifth day post-operatively you are asked to review his abdominal wound due to concerns from the nursing staff. There is obvious wound dehiscence in the central part of his laparotomy incision and small bowel is visible.<br /><br />What are the most appropriate initial steps to be taken in this scenario?",
        "correct_answer": "2",
        "question_notes": "Wound dehiscence is when a surgical wound reopens, either partially or entirely. It can occur any time after an operation and affect any surgical wound on any part of the body. A number of factors increase the risk of dehiscence including infection, malnutrition and poor surgical technique. The emergency management of abdominal wound dehiscence is important to know as junior doctors are almost certainly going to be the first person to confront this problem on the ward when it occurs. The initial management is treating with intravenous antibiotics, covering the wound with sterile gauze soaked in sterile saline to ensure the abdominal contents do not dry out and arranging for the patient to be taken to theatre for a wound repair.<br /><br />Attempting to close the wound on the ward yourself is both unlikely to succeed and unsafe as the risk of infection or bowel injury is high.<br /><br />A nasogastric tube is not indicated and simply redressing the wound without applying moist gauze is likely to risk transudative volume loss from the abdominal contents. An open body compartment can result in a significant loss of fluid if not managed appropriately and this makes this option less appropriate. Additionally, there is a risk of passing a nasogastric tube with an open abdomen as it can cause coughing and abdominal muscle straining and result in widening of the wound defect.<br /><br />Arranging a CT scan is not necessary in this situation, the problem is very obvious and a scan will only delay definitive management.<br /><br />Although antibiotics and returning to theatre are both required, not dealing with the open wound in any way is a poor choice. Leaving an open wound uncovered risks both fluid loss and infection entering.",
        "answer_order": "2",
        "answer": "2",
        "title": "Abdominal wound dehiscence",
        "body": "Abdominal wound dehiscence is a significant problem facing all surgeons who undertake abdominal surgery on a regular basis. Traditionally, it is said to occur when all layers of an abdominal mass closure fail and the viscera protrude externally (associated with 30% mortality). <br /><br />It can be subdivided into <b>superficial</b>, in which the skin wound alone fails and <b>complete</b>, implying failure of all layers.<br /><br />Factors that increase the risk are:<br /><ul><li>Malnutrition</li><li>Vitamin deficiencies </li><li>Jaundice </li><li>Steroid use </li><li>Major wound contamination (e.g. faecal peritonitis)</li><li>Poor surgical technique (Mass closure technique is the preferred method-Jenkins Rule)</li></ul><br />When sudden full dehiscence occurs the management is as follows:<br /><ul><li><span class=\"concept\" data-cid=\"11281\">Coverage of the wound with saline impregnated gauze (on the ward)</span></li><li><span class=\"concept\" data-cid=\"11281\">IV broad-spectrum antibiotics</span></li><li>Analgesia</li><li>IV fluids</li><li>Arrangements made for a return to theatre</li></ul>",
        "notes_hash": "2638dc7d45f0065c45fbee4b775eb704",
        "knowledge_graph_node_id_link": 0,
        "concept": "Abdominal wound dehiscence should initially be managed with coverage of the wound with saline impregnated gauze + IV broad-spectrum antibiotics",
        "concept_percentile": "91",
        "concept_colour": "rgb(45,255,0)",
        "number_attempts": "5999",
        "up_votes": "46",
        "down_votes": "45",
        "column_array": [
            0,
            "29",
            "3866",
            "434",
            "174",
            "1496",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "",
        "comment_count": 7,
        "concepts_for_notes": {
            "11281": {
                "concept_text": "Abdominal wound dehiscence should initially be managed with coverage of the wound with saline impregnated gauze + IV broad-spectrum antibiotics",
                "concept_percentile": "91"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "999_B_2157",
        "new_question_id": "61238",
        "question_type": "0",
        "category": "12",
        "concept_id_link": "6117",
        "notes_id_link": "1_1212",
        "theme": "First-line antibiotic choice for infective COPD exacerbation",
        "instruction": "",
        "options": [
            "",
            "Amoxicillin",
            "Co-amoxiclav",
            "Ciprofloxacin",
            "Azithromycin",
            "Trimethoprim",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 68-year-old man with known COPD presents to his GP with a 3-day history of worsening breathlessness and increased cough. He reports his sputum has changed from white to green. Examination reveals widespread wheeze and oxygen saturation of 93% on air. He has no drug allergies.<br /><br />Select the single most appropriate antibiotic from the options below.",
            "",
            ""
        ],
        "answers": [
            "1",
            "",
            ""
        ],
        "notes": [
            "<b>Amoxicillin</b> is the correct answer as it is one of the three first-line antibiotics recommended by NICE and the BNF for infective exacerbations of COPD. This patient has clear evidence of an infective exacerbation with purulent (green) sputum, which is an indication for antibiotic therapy according to NICE guidelines. The most common bacterial pathogens in COPD exacerbations are <i>Haemophilus influenzae</i>, <i>Streptococcus pneumoniae</i>, and <i>Moraxella catarrhalis</i>. Amoxicillin provides appropriate coverage for these organisms and is well-tolerated with a good safety profile. The other first-line options would be clarithromycin (useful if penicillin allergy) or doxycycline. As this patient has no drug allergies, amoxicillin represents an appropriate and cost-effective first-line choice. It is important to remember that antibiotics should only be prescribed in COPD exacerbations when there is purulent sputum or clinical signs of pneumonia, not routinely for all exacerbations.<br /><br /><b>Co-amoxiclav</b> is not recommended as a first-line antibiotic for COPD exacerbations. While it provides broader spectrum coverage including beta-lactamase producing organisms, it is reserved for second-line therapy when first-line antibiotics have failed or in more severe infections requiring hospital admission. Using co-amoxiclav as first-line therapy would represent unnecessary broad-spectrum antibiotic use, contributing to antimicrobial resistance. The additional clavulanic acid component increases the risk of side effects, particularly diarrhoea, without proven benefit in uncomplicated community-managed COPD exacerbations. First-line therapy should always be attempted before escalating to broader spectrum agents.<br /><br /><b>Ciprofloxacin</b> is a fluoroquinolone antibiotic that is not recommended for routine treatment of COPD exacerbations in UK guidelines. While it has activity against some respiratory pathogens including <i>Haemophilus influenzae</i>, it is not listed as a first-line option by NICE or the BNF. Fluoroquinolones are associated with significant side effects including tendon rupture, particularly in older patients, and their use should be restricted to specific indications to preserve their effectiveness. They may be considered in selected cases of severe exacerbations or when first-line antibiotics have failed, but this would typically be in a secondary care setting with specialist input.<br /><br /><b>Azithromycin</b> is a macrolide antibiotic but is not the preferred first-line macrolide for COPD exacerbations in UK guidelines. Clarithromycin is the recommended first-line macrolide option. While azithromycin has good activity against typical respiratory pathogens and the advantage of a shorter course (typically 3 days), it is not listed in the BNF as a first-line choice for this indication. Azithromycin may have a role in prophylaxis for patients with frequent exacerbations, but for acute treatment of an infective exacerbation, clarithromycin would be the preferred macrolide if a penicillin allergy existed or as an alternative first-line agent.<br /><br /><b>Trimethoprim</b> is completely inappropriate for treating respiratory tract infections and COPD exacerbations. This antibiotic is primarily used for urinary tract infections and has poor activity against the common respiratory pathogens that cause COPD exacerbations, including <i>Haemophilus influenzae</i>, <i>Streptococcus pneumoniae</i>, and <i>Moraxella catarrhalis</i>. Prescribing trimethoprim for this indication would represent a significant prescribing error and would not provide adequate treatment for the patient's infective exacerbation. It demonstrates the importance of selecting antibiotics based on the likely causative organisms and following evidence-based guidelines for specific clinical scenarios.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 68-year-old man with known COPD presents to his GP with a 3-day history of worsening breathlessness and increased cough. He reports his sputum has changed from white to green. Examination reveals widespread wheeze and oxygen saturation of 93% on air. He has no drug allergies.<br /><br />Select the single most appropriate antibiotic from the options below.",
        "correct_answer": "1",
        "question_notes": "<b>Amoxicillin</b> is the correct answer as it is one of the three first-line antibiotics recommended by NICE and the BNF for infective exacerbations of COPD. This patient has clear evidence of an infective exacerbation with purulent (green) sputum, which is an indication for antibiotic therapy according to NICE guidelines. The most common bacterial pathogens in COPD exacerbations are <i>Haemophilus influenzae</i>, <i>Streptococcus pneumoniae</i>, and <i>Moraxella catarrhalis</i>. Amoxicillin provides appropriate coverage for these organisms and is well-tolerated with a good safety profile. The other first-line options would be clarithromycin (useful if penicillin allergy) or doxycycline. As this patient has no drug allergies, amoxicillin represents an appropriate and cost-effective first-line choice. It is important to remember that antibiotics should only be prescribed in COPD exacerbations when there is purulent sputum or clinical signs of pneumonia, not routinely for all exacerbations.<br /><br /><b>Co-amoxiclav</b> is not recommended as a first-line antibiotic for COPD exacerbations. While it provides broader spectrum coverage including beta-lactamase producing organisms, it is reserved for second-line therapy when first-line antibiotics have failed or in more severe infections requiring hospital admission. Using co-amoxiclav as first-line therapy would represent unnecessary broad-spectrum antibiotic use, contributing to antimicrobial resistance. The additional clavulanic acid component increases the risk of side effects, particularly diarrhoea, without proven benefit in uncomplicated community-managed COPD exacerbations. First-line therapy should always be attempted before escalating to broader spectrum agents.<br /><br /><b>Ciprofloxacin</b> is a fluoroquinolone antibiotic that is not recommended for routine treatment of COPD exacerbations in UK guidelines. While it has activity against some respiratory pathogens including <i>Haemophilus influenzae</i>, it is not listed as a first-line option by NICE or the BNF. Fluoroquinolones are associated with significant side effects including tendon rupture, particularly in older patients, and their use should be restricted to specific indications to preserve their effectiveness. They may be considered in selected cases of severe exacerbations or when first-line antibiotics have failed, but this would typically be in a secondary care setting with specialist input.<br /><br /><b>Azithromycin</b> is a macrolide antibiotic but is not the preferred first-line macrolide for COPD exacerbations in UK guidelines. Clarithromycin is the recommended first-line macrolide option. While azithromycin has good activity against typical respiratory pathogens and the advantage of a shorter course (typically 3 days), it is not listed in the BNF as a first-line choice for this indication. Azithromycin may have a role in prophylaxis for patients with frequent exacerbations, but for acute treatment of an infective exacerbation, clarithromycin would be the preferred macrolide if a penicillin allergy existed or as an alternative first-line agent.<br /><br /><b>Trimethoprim</b> is completely inappropriate for treating respiratory tract infections and COPD exacerbations. This antibiotic is primarily used for urinary tract infections and has poor activity against the common respiratory pathogens that cause COPD exacerbations, including <i>Haemophilus influenzae</i>, <i>Streptococcus pneumoniae</i>, and <i>Moraxella catarrhalis</i>. Prescribing trimethoprim for this indication would represent a significant prescribing error and would not provide adequate treatment for the patient's infective exacerbation. It demonstrates the importance of selecting antibiotics based on the likely causative organisms and following evidence-based guidelines for specific clinical scenarios.",
        "answer_order": "1",
        "answer": "1",
        "title": "Acute exacerbation of COPD",
        "body": "Acute exacerbations of COPD are one of the most common reasons why people present to hospital in developed countries.<br /><br />The most common infective causes of COPD exacerbations are:<br /><ul><li>bacteria<ul><li><span class=\"concept\" data-cid=\"5077\"><i>Haemophilus influenzae</i> (most common cause)</span></li><li><i>Streptococcus pneumoniae</i></li><li><i>Moraxella catarrhalis</i></li></ul></li><li>respiratory viruses<ul><li>account for around 30% of exacerbations</li><li>human rhinovirus is the most important pathogen</li></ul></li></ul><br />Features<br /><ul><li>increase in dyspnoea, cough, wheeze</li><li>there may be an increase in sputum suggestive of an infective cause</li><li>patients may be hypoxic and in some cases have acute confusion</li></ul><br />NICE guidelines from 2010 recommend the following:<br /><ul><li>increase the frequency of bronchodilator use and consider giving via a nebuliser</li><li>give prednisolone 30 mg daily for <span class=\"concept\" data-cid=\"10968\">5 days</span></li><li>it is common practice for all patients with an exacerbation of COPD to receive antibiotics. NICE do not support this approach. They recommend giving oral antibiotics <span class=\"concept\" data-cid=\"7722\">'if sputum is purulent or there are clinical signs of pneumonia'</span></li><li>the BNF recommends one of the following oral antibiotics first-line: <span class=\"concept\" data-cid=\"6117\">amoxicillin or clarithromycin or doxycycline.</span></li></ul><br />Admission is recommended if any of the following criteria are met<br /><ul><li>severe breathlessness</li><li>acute confusion or impaired consciousness</li><li>cyanosis</li><li>oxygen saturation less than 90% on pulse oximetry.</li><li>social reasons e.g. inability to cope at home (or living alone)</li><li>significant comorbidity (such as cardiac disease or insulin-dependent diabetes)</li></ul><br /><br /><h5 class='notes-heading'>Severe exacerbations requiring secondary care</h5><br />Oxygen therapy<br /><ul><li>COPD patients are at risk of hypercapnia - therefore an initial oxygen saturation target of 88-92% should be used</li><li>prior to the availability of blood gases, use a 28% Venturi mask at 4 l/min and aim for an oxygen saturation of 88-92% for patients with risk factors for hypercapnia but no prior history of respiratory acidosis</li><li>adjust target range to 94-98% if the pCO2 is normal</li></ul><br />Nebulised bronchodilator<br /><ul><li>beta adrenergic agonist: e.g. salbutamol</li><li>muscarinic antagonists: e.g. ipratropium</li></ul><br />Steroid therapy as above<br /><ul><li>IV hydrocortisone may sometimes be considered instead of oral prednisolone</li></ul><br />IV theophylline<br /><ul><li>may be considered for patients not responding to nebulised bronchodilators</li></ul><br />Patients with COPD are prone to develop type 2 respiratory failure. If this develops then <span class=\"concept\" data-cid=\"7721\">non-invasive ventilation</span> may be used<br /><ul><li>typically used for COPD with respiratory acidosis pH 7.25-7.35<ul><li>the BTS guidelines state that NIV can be used in patients who are more acidotic (i.e. pH < 7.25) but that a greater degree of monitoring is required (e.g. HDU) and a lower threshold for intubation and ventilation should be used</li></ul></li><li>bilevel positive airway pressure (BiPaP) is typically used with initial settings:<ul><li>Expiratory Positive Airway Pressure (EPAP): 4-5 cm H2O. Consider increasing EPAP if hypoxia despite adequate ventilation</li><li>Inspiratory Positive Airway Pressure (IPAP): RCP advocate 10 cm H20 whilst BTS suggest 12-15 cm H2O. <span class=\"concept\" data-cid=\"12533\">IPAP should be gradually increased if persistently high or rising pCO\u2082 with low pH (<7.30)</span>. As IPAP rises, need to monitor patient comfort/tolerance, air leaks, gastric distension etc</li></ul></li></ul>",
        "notes_hash": "9bf7c5c616032ad8ff893095d841dec2",
        "knowledge_graph_node_id_link": 1496,
        "concept": "Infective exacerbation of COPD: first-line antibiotics are amoxicillin or clarithromycin or doxycycline",
        "concept_percentile": "27",
        "concept_colour": "rgb(255,137,0)",
        "number_attempts": "445",
        "up_votes": "1",
        "down_votes": "1",
        "column_array": [
            0,
            "226",
            "106",
            "17",
            "95",
            "1",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1474\" data-linkid=\"1474\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1474\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">29</span><button type=\"button\" style=\"\" id=\"link_dislike_1474\" data-linkid=\"1474\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1474\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">15</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng115/chapter/Recommendations\">2018 COPD guidelines</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/OHQK5PUTQ_0\" data-description=\"CPAP and Non-Invasive Ventilation in 5 minutes\" data-upvotes=\"28\" data-downvotes=\"3\" data-media=\"478\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/OHQK5PUTQ_0/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/OHQK5PUTQ_0\" data-description=\"CPAP and Non-Invasive Ventilation in 5 minutes\" data-upvotes=\"28\" data-downvotes=\"3\" data-media=\"478\">CPAP and Non-Invasive Ventilation in 5 minutes</a></td></tr><tr><td><span ><small>Nick Smith - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_839\" data-mediaid=\"839\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_839\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">28</span><button type=\"button\" style=\"\" id=\"media_dislike_839\" data-mediaid=\"839\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_839\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">3</span></td></tr></table>",
        "comment_count": 0,
        "concepts_for_notes": {
            "5077": {
                "concept_text": "The most common organism causing infective exacerbations of COPD is <i>Haemophilus influenzae</i>",
                "concept_percentile": "82"
            },
            "6117": {
                "concept_text": "Infective exacerbation of COPD: first-line antibiotics are amoxicillin or clarithromycin or doxycycline",
                "concept_percentile": "27"
            },
            "7721": {
                "concept_text": "Acute exacerbation of COPD: BiPaP is indicated if type 2 respiratory failure develops despite medical therapy",
                "concept_percentile": "94"
            },
            "7722": {
                "concept_text": "NICE only recommend giving oral antibiotics in an acute exacerbation of COPD in the presence of purulent sputum or clinical signs of pneumonia",
                "concept_percentile": "79"
            }
        },
        "optimisation_reason": ""
    }
]